Literature DB >> 17982880

Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals.

T Wultsch1, S Chourbaji, S Fritzen, S Kittel, E Grünblatt, M Gerlach, L Gutknecht, F Chizat, G Golfier, A Schmitt, P Gass, K P Lesch, A Reif.   

Abstract

The gaseous messenger nitric oxide (NO) has been implicated in a wide range of behaviors, including aggression, anxiety, depression, and cognitive functioning. To further elucidate the physiological role of NO and its down-stream mechanisms, we conducted behavioral and expressional phenotyping of mice lacking the neuronal isoform of nitric oxide synthase (NOS-I), the major source of NO in the central nervous system. No differences were observed in activity-related parameters; in contrast to the a priori hypothesis, derived from pharmacological treatments, depression-related tests (Forced Swim Test, Learned Helplessness) also yielded no significantly different results. A subtle anxiolytic phenotype however was present, with knockdown mice displaying a higher open arm time as compared to their respective wildtypes, yet all other investigated anxiety-related parameters were unchanged. The most prominent feature however was gender-independent cognitive impairment in spatial learning and memory, as assessed by the Water Maze test and an automatized holeboard paradigm. No significant dysregulation of monoamine transporters was evidenced by qRT PCR. To further examine the underlying molecular mechanisms, the transcriptome of knockdown animals was thus examined in the hippocampus, striatum and cerebellum by microarray analysis. A set of >120 differentially expressed genes was identified, whereat the hippocampus and the striatum showed similar expressional profiles as compared to the cerebellum in hierarchical clustering. Among the most significantly up-regulated genes were Peroxiredoxon 3, Atonal homologue 1, Kcnj1, Kcnj8, CCAAT/enhancer binding protein (C/EBP), alpha, 3 genes involved in GABA(B) signalling and, intriguingly, the glucocorticoid receptor GR. While GABAergic genes might underlie reduced anxiety, dysregulation of the glucocorticoid receptor can well contribute to a blunted stress response as found in NOS1 knockdown mice. Furthermore, by CREB inhibition, glucocorticoid receptor upregulation could at least partially explain cognitive deficits in these animals. Taken together, NOS1 knockdown mice display a characteristic behavioural profile consisting of reduced anxiety and impaired learning and memory, paralleled by differential expression of the glucocorticoid receptor and GABAergic genes. Further research has to assess the value of these mice as animal models e.g. for Alzheimer's disease or attention deficit disorder, in order to clarify a possible pathophysiological role of NO therein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982880     DOI: 10.1007/978-3-211-73574-9_10

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  18 in total

1.  NOS1 ex1f-VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks.

Authors:  Juliane Kopf; Martin Schecklmann; Tim Hahn; Alica C Dieler; Martin J Herrmann; Andreas J Fallgatter; Andreas Reif
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

2.  Lacidipine attenuates reserpine-induced depression-like behavior and oxido-nitrosative stress in mice.

Authors:  Kunal Khurana; Nitin Bansal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-11       Impact factor: 3.000

3.  Imbalance between nitric oxide and dopamine may underly aggression in acute neurological patients.

Authors:  J Ramírez-Bermudez; I Perez-Neri; S Montes; M Ramirez-Abascal; F Nente; A Abundes-Corona; J L Soto-Hernandez; C Rios
Journal:  Neurochem Res       Date:  2010-08-01       Impact factor: 3.996

4.  The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity.

Authors:  Kariina Laas; Andreas Reif; Sabine Herterich; Diva Eensoo; Klaus-Peter Lesch; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

5.  Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer.

Authors:  Christian Geis; Benedikt Grünewald; Andreas Weishaupt; Thomas Wultsch; Klaus V Toyka; Andreas Reif; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2012-02-14       Impact factor: 3.575

6.  Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

Authors:  Abbas K Ali; William A Banks; Vijaya B Kumar; Gul N Shah; Jessica L Lynch; Susan A Farr; Melissa A Fleegal-DeMotta; John E Morley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-16       Impact factor: 6.053

7.  Effects of restraint stress and nitric oxide synthase inhibition on learning and strategy preference in young adult male rats.

Authors:  Melih Dağdeviren; Yusuf Hakan Doğan; Lütfiye Kanıt
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

8.  An investigation of hypofrontality in an animal model of schizophrenia using real-time microelectrochemical sensors for glucose, oxygen, and nitric oxide.

Authors:  Niall J Finnerty; Fiachra B Bolger; Erik Pålsson; John P Lowry
Journal:  ACS Chem Neurosci       Date:  2013-04-25       Impact factor: 4.418

9.  Human stiff-person syndrome IgG induces anxious behavior in rats.

Authors:  Christian Geis; Andreas Weishaupt; Benedikt Grünewald; Thomas Wultsch; Andreas Reif; Manfred Gerlach; Ron Dirkx; Michele Solimena; Daniela Perani; Manfred Heckmann; Klaus V Toyka; Franco Folli; Claudia Sommer
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

10.  Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.

Authors:  Sabrina F Lisboa; Felipe V Gomes; Andréia L Silva; Daniela L Uliana; Laura H A Camargo; Francisco S Guimarães; Fernando Q Cunha; Sâmia R L Joca; Leonardo B M Resstel
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-24       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.